LRRC32 and lung cancer: Our data suggested that the proportion of GARP+ cells in Tregs from lung cancer patients without lymphatic invasion was higher than that from patients with lymphatic invasion [12.90% (4.090%, 52.13%) vs. 7.470% (2.920%, 10.10%)] while the MFI of GARP expression in Tregs was in accordance with GARP+ cell proportion (2,510 ± 1,176 vs. 1,724 ± 803.4) (Figure 2A).